Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

INGN-241: new data presented at the Boston gene therapy meeting

June 13, 2002

Multiple doses of NV-1020 feasible; efficacy demonstrated in pancreatic cancer peritoneal metastasis

June 13, 2002

Multidrug resistance modulators identified at Procter & Gamble

June 13, 2002

Oncopharm patents antitumor cephalotaxines

June 13, 2002

Promising results reported for Trisenox in myelodysplastic syndromes

June 12, 2002

Adherex Technologies updates Exherin progress

June 12, 2002

Antiproliferative sulindac derivative targets the Ras pathway

June 12, 2002

TranzVector-mediated delivery of human IFNbeta gene effective in human tumor xenograft model

June 12, 2002

Adenovirus-mediated ribonucleotide reductase gene therapy inhibits human colon cancer growth

June 12, 2002

Protein kinase inhibitors in development at Morphochem

June 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...